Cargando…

Immunological imprinting of the antibody response in COVID-19 patients

In addition to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), humans are also susceptible to six other coronaviruses, for which consecutive exposures to antigenically related and divergent seasonal coronaviruses are frequent. Despite the prevalence of COVID-19 pandemic and ongoing res...

Descripción completa

Detalles Bibliográficos
Autores principales: Aydillo, Teresa, Rombauts, Alexander, Stadlbauer, Daniel, Aslam, Sadaf, Abelenda-Alonso, Gabriela, Escalera, Alba, Amanat, Fatima, Jiang, Kaijun, Krammer, Florian, Carratala, Jordi, García-Sastre, Adolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213790/
https://www.ncbi.nlm.nih.gov/pubmed/34145263
http://dx.doi.org/10.1038/s41467-021-23977-1
_version_ 1783709928626585600
author Aydillo, Teresa
Rombauts, Alexander
Stadlbauer, Daniel
Aslam, Sadaf
Abelenda-Alonso, Gabriela
Escalera, Alba
Amanat, Fatima
Jiang, Kaijun
Krammer, Florian
Carratala, Jordi
García-Sastre, Adolfo
author_facet Aydillo, Teresa
Rombauts, Alexander
Stadlbauer, Daniel
Aslam, Sadaf
Abelenda-Alonso, Gabriela
Escalera, Alba
Amanat, Fatima
Jiang, Kaijun
Krammer, Florian
Carratala, Jordi
García-Sastre, Adolfo
author_sort Aydillo, Teresa
collection PubMed
description In addition to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), humans are also susceptible to six other coronaviruses, for which consecutive exposures to antigenically related and divergent seasonal coronaviruses are frequent. Despite the prevalence of COVID-19 pandemic and ongoing research, the nature of the antibody response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. Here we longitudinally profile the early humoral immune response against SARS-CoV-2 in hospitalized coronavirus disease 2019 (COVID-19) patients and quantify levels of pre-existing immunity to OC43, HKU1 and 229E seasonal coronaviruses, and find a strong back-boosting effect to conserved but not variable regions of OC43 and HKU1 betacoronaviruses spike protein. However, such antibody memory boost to human coronaviruses negatively correlates with the induction of IgG and IgM against SARS-CoV-2 spike and nucleocapsid protein. Our findings thus provide evidence of immunological imprinting by previous seasonal coronavirus infections that can potentially modulate the antibody profile to SARS-CoV-2 infection.
format Online
Article
Text
id pubmed-8213790
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82137902021-07-01 Immunological imprinting of the antibody response in COVID-19 patients Aydillo, Teresa Rombauts, Alexander Stadlbauer, Daniel Aslam, Sadaf Abelenda-Alonso, Gabriela Escalera, Alba Amanat, Fatima Jiang, Kaijun Krammer, Florian Carratala, Jordi García-Sastre, Adolfo Nat Commun Article In addition to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), humans are also susceptible to six other coronaviruses, for which consecutive exposures to antigenically related and divergent seasonal coronaviruses are frequent. Despite the prevalence of COVID-19 pandemic and ongoing research, the nature of the antibody response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. Here we longitudinally profile the early humoral immune response against SARS-CoV-2 in hospitalized coronavirus disease 2019 (COVID-19) patients and quantify levels of pre-existing immunity to OC43, HKU1 and 229E seasonal coronaviruses, and find a strong back-boosting effect to conserved but not variable regions of OC43 and HKU1 betacoronaviruses spike protein. However, such antibody memory boost to human coronaviruses negatively correlates with the induction of IgG and IgM against SARS-CoV-2 spike and nucleocapsid protein. Our findings thus provide evidence of immunological imprinting by previous seasonal coronavirus infections that can potentially modulate the antibody profile to SARS-CoV-2 infection. Nature Publishing Group UK 2021-06-18 /pmc/articles/PMC8213790/ /pubmed/34145263 http://dx.doi.org/10.1038/s41467-021-23977-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Aydillo, Teresa
Rombauts, Alexander
Stadlbauer, Daniel
Aslam, Sadaf
Abelenda-Alonso, Gabriela
Escalera, Alba
Amanat, Fatima
Jiang, Kaijun
Krammer, Florian
Carratala, Jordi
García-Sastre, Adolfo
Immunological imprinting of the antibody response in COVID-19 patients
title Immunological imprinting of the antibody response in COVID-19 patients
title_full Immunological imprinting of the antibody response in COVID-19 patients
title_fullStr Immunological imprinting of the antibody response in COVID-19 patients
title_full_unstemmed Immunological imprinting of the antibody response in COVID-19 patients
title_short Immunological imprinting of the antibody response in COVID-19 patients
title_sort immunological imprinting of the antibody response in covid-19 patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213790/
https://www.ncbi.nlm.nih.gov/pubmed/34145263
http://dx.doi.org/10.1038/s41467-021-23977-1
work_keys_str_mv AT aydilloteresa immunologicalimprintingoftheantibodyresponseincovid19patients
AT rombautsalexander immunologicalimprintingoftheantibodyresponseincovid19patients
AT stadlbauerdaniel immunologicalimprintingoftheantibodyresponseincovid19patients
AT aslamsadaf immunologicalimprintingoftheantibodyresponseincovid19patients
AT abelendaalonsogabriela immunologicalimprintingoftheantibodyresponseincovid19patients
AT escaleraalba immunologicalimprintingoftheantibodyresponseincovid19patients
AT amanatfatima immunologicalimprintingoftheantibodyresponseincovid19patients
AT jiangkaijun immunologicalimprintingoftheantibodyresponseincovid19patients
AT krammerflorian immunologicalimprintingoftheantibodyresponseincovid19patients
AT carratalajordi immunologicalimprintingoftheantibodyresponseincovid19patients
AT garciasastreadolfo immunologicalimprintingoftheantibodyresponseincovid19patients